AstraZeneca lifts full-year outlook on upbeat demand for therapies By Reuters
(Reuters) -Anglo-Swedish drugmaker AstraZeneca (NASDAQ:) on Thursday raised its sales and profit forecast for 2024 and topped analyst expectations for...
(Reuters) -Anglo-Swedish drugmaker AstraZeneca (NASDAQ:) on Thursday raised its sales and profit forecast for 2024 and topped analyst expectations for...